PrimSol (Allegis Holdings, LLC)
Welcome to the PulseAid listing for the PrimSol drug offered from Allegis Holdings, LLC. This Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allegis Holdings, LLC |
| NON-PROPRIETARY NAME: | TRIMETHOPRIM HYDROCHLORIDE |
| SUBSTANCE NAME: | TRIMETHOPRIM HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-05-04 |
| END MARKETING DATE: | 0000-00-00 |
PrimSol HUMAN PRESCRIPTION DRUG Details:
| Item Description | PrimSol from Allegis Holdings, LLC |
| LABELER NAME: | Allegis Holdings, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/5mL) |
| START MARKETING DATE: | 2017-05-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 71297-500_9342b462-0983-4c9f-9b0e-e998b1061b31 |
| PRODUCT NDC: | 71297-500 |
| APPLICATION NUMBER: | NDA074973 |
Other TRIMETHOPRIM HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
